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Abstract. We estimated the pre-intervention prevalence of Trypanosoma brucei gambiense (Tbg) trypanosomiasis
using the lot quality assurance sampling (LQAS) methods in 14 parishes of Terego County in northern Uganda. A total
of 826 participants were included in the survey sample in 1996. The prevalence of laboratory confirmed Tbg trypano-
somiasis adjusted for parish population sizes was 2.2% (95% confidence interval  1.1−3.2). This estimate was consistent
with the 1.1% period prevalence calculated on the basis of cases identified through passive and active screening in
1996−1999. Ranking of parishes in four categories according to LQAS analysis of the 1996 survey predicted the
prevalences observed during the first round of active screening in the population in 1997−1998 (P < 0.0001, by chi-square
test). Overall prevalence and ranking of parishes obtained with LQAS were validated by the results of the population
screening, suggesting that these survey methods may be useful in the pre-intervention phase of sleeping sickness control
programs.
INTRODUCTION
Trypanosoma brucei gambiense (Tbg) trypanosomiasis
(sleeping sickness) is a chronic parasitic disease that has a
long initial asymptomatic phase and that is 100% lethal in the
absence of treatment. Humans acquire infection through the
bite of an infected Glossina (tsetse fly), usually in selected
human-vector contact sites.
1 In the foci of the disease, villages
where active transmission occurs have higher prevalences. In-
terventions are based upon a combination of 1) active screen-
ing for the treatment of all cases and 2) vector control. Such
programs are resource-intensive because they require mobile
teams for mass screening, a laboratory diagnosis capacity, and
treatment facilities capable of caring for a high number of
patients.
When sleeping sickness re-emerges in an historic focus, es-
timation of the overall prevalence will allow overall planning
of resources, while identification of high prevalence villages
will determine which sites may host active transmission. Clas-
sic survey methods allow estimating the overall prevalence,
but they cannot be used to identify high prevalence villages
because the sample size required, one stratum per village,
would be too large. Lot quality assurance sampling (LQAS) is
an alternative sampling method originally designed to test
batches of industrial products and efficiently identify those
where the acceptable failure rate is exceeded.
2 While tradi-
tional survey methods aim at estimating a quantified param-
eter, LQAS is based upon the qualitative testing of a hypoth-
esis that is accepted or rejected. Thus, LQAS provides less
information than traditional methods. However, it requires
much smaller sample sizes and was found to be useful in a
number of public health settings, including immunization cov-
erage surveys.
3 LQAS has never been used for sleeping sick-
ness prevalence surveys. However, the ability to compare
strata within a larger sample makes it a method that is
adapted to the heterogeneous distribution of Tbg trypanoso-
miasis in populations.
Since 1980, Tbg trypanosomiasis has re-emerged in north-
ern Uganda as in other sub-Saharan African historic foci.
4−8
The National Sleeping Sickness Control Program (NSSCP)
has conducted control activities in the West Nile region (Arua
and Moyo district) in collaboration with Médecins Sans Fron-
tières since 1986 using diagnosis and treatment protocols de-
fined in an agreement with the World Health Organization.
From 1987 to 1991, 80−90% of the population of the western
part of the Moyo district was screened through passive and
active methods and 4,822 patients were diagnosed and treated
in the treatment center of Moyo Hospital between 1987 and
1992.
5 A second center, exclusively oriented toward sleeping
sickness, opened a passive screening program in September
1991 in Adjumani in the eastern part of the Moyo district.
This was followed between 1992 and 1996 by an active mass
screening campaign that resulted in the treatment of 5,423
patients (as of December 1999, Médecins Sans Frontières un-
published data). In September 1995, while sleeping sickness
was under control in the Moyo district, cases of this disease
were reported in Terego County in the neighboring district of
Arua . Thus, a sleeping sickness diagnosis and treatment cen-
ter was opened in the village of Omugo in the Arua district.
As of April 1996, 447 Terego county residents with Tbg try-
panosomiasis were self-referred for diagnosis and treatment
at the center, suggesting active current local transmission. To
better direct the planned active screening efforts, we con-
ducted a cross-sectional survey in April−May 1996. The ob-
jectives of the survey were to 1) obtain a pre-intervention
estimate of the prevalence of Tbg trypanosomiasis in Terego
County and 2) identify high prevalence parishes that required
an intervention before the others. We thus used the LQAS
methods to achieve these two objectives while maintaining a
manageable sample size.
METHODS
Diagnosis of Tbg trypanosomiasis is made through sero-
logic screening followed by parasitologic diagnostic proce-
dures. Serologic testing is conducted using the card aggluti-
nation trypanosomiasis test (CATT),
9 a serologic test that can
be performed with increasing dilutions of serum to increase
its specificity. Parasitologic diagnostic procedures are based
upon microscopic examination of lymph nodes aspirates,
blood, or cerebrospinal fluid for evidence of Tbg.
Case definitions. Three levels of case definition with in-
creasing specificity were used. First, a positive CATT result
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390was defined as a visible agglutination on the card test using a
whole blood specimen. This case definition was most sensitive
but least specific. Second, a serologically suspected case was
defined as a positive CATT result using a serum at a 1:4
dilution. This case definition had an intermediate level of
sensitivity and specificity. Third, a confirmed case of Tbg try-
panosomiasis was defined as parasitologic evidence of Tbg
infection in the blood, lymph nodes, or cerebrospinal fluid.
This case definition was less sensitive but most specific.
Sampling methods. The survey population was defined as
the population of the 24 parishes of Terego County. This
sample was stratified by parish. In each of the 24 parishes,
households were randomly selected from a list obtained from
the local authorities and key informants. Within each selected
household, one individual was selected at random.
Laboratory testing. All participants were screened in the
field using a CATT on whole blood. Patients with a positive
CATT result were referred to the diagnosis and treatment
center for a CATT on a serum specimen diluted 1:4 and di-
agnostic investigations according to the algorithm used in the
NSSCP.
5 Briefly, serologically suspected cases were investi-
gated for parasitologic evidence of Tbg infection. Patients
presenting with cervical lymphadenopathies underwent a
glandular puncture for microscopic analysis. When there was
no evidence of Tbg infection in any lymph node, blood
samples were examined using the Woo concentration tech-
nique,
10 followed by the quantitative buffy coat technique if
the Woo test result was negative.
11 Finally, a lumbar puncture
for microscopic analysis of cerebrospinal fluid was done for
all serologically suspected cases. These suspected cases for
which no infection could be detected during the initial visit
were actively followed-up by specialized community health
workers (sleeping sickness assistants) and brought back to the
Omugo Center for four visits during the next 12 months, as
per the national protocol.
Statistical analysis. Analysis of the survey. The LQAS
method allowed testing the hypothesis that the prevalence in
a given parish was below a certain threshold.
2 If the observed
number of cases among the n subjects selected in a parish was
less or equal a critical number (d), the prevalence could be
considered to be lower than a high threshold (T1) in this
parish with a defined alpha error. If n exceeded d, the preva-
lence could not be considered to be lower than the high
threshold (T1) in this parish with the defined alpha error.
Power calculations then suggested that in these parishes,
there was probability equal to 1 - the beta error that the
prevalence exceeded a lower threshold (T2).
Parishes were ranked in categories according to the LQAS
analysis results for the three case definitions used. Parishes
that exceeded the critical number d for the three case defini-
tions were ranked in the ++++ category, parishes that ex-
ceeded the critical number for two were ranked in the +++
category, parishes that exceeded the critical number for one
were ranked in the ++ category, and the remainder that never
exceeded the critical number d were ranked in the + category.
Following this parish-specific LQAS statistical analysis, all
parishes were pooled to measure the overall prevalence in
Terego County, as in an ordinary stratified random sample.
3
Prevalence estimates were adjusted for population sizes since
an equal number of participants was selected from each par-
ish that in fact had different population sizes.
Validation of the survey results. To validate the ranking of
parishes obtained with the LQAS analysis, prevalences cal-
culated during the initial active screening conducted between
1997 and 1998 were compared with the ranking of parishes in
the four LQAS categories. The years 1997−1998 represented
the first active screening round following the survey because
no active screening could be done immediately after the sur-
vey in 1996 due to civil unrest in the county.
To validate the overall county prevalence estimate, the
prevalence estimate obtained through the survey was com-
pared with the period prevalence calculated on the basis of
the total number of cases identified as a result of combined
active and passive screening after the survey from 1996 to
1999. In all calculations, 1991 national census figures were
projected to 1996 using a 3% crude annual growth rate as
reported in the 1991 national census.
Sample size. Use of the LQAS tables allowed an arbitrary
choice of n and d.
2 These indicated that if 1) n  59 indi-
viduals were selected in each parish and 2) the number of
identified cases was less than or equal to d  2, the preva-
lence in the parish could be hypothesized not to exceed the T1
10% threshold with an alpha risk of 5%. Power calculations
for such a sample size indicated that in parishes were the
number of cases exceeded d  2, the probability that the
prevalence exceeded the T2 threshold 2% was 80%.
2 These
choices of n and d were adapted to the decisions expected to
be made on the basis of the results of the survey.
The expected overall sample size for Terego County was
1,416 (i.e., 24 strata of 59 individuals). Given the 1996 Terego
County population size (115,203) and assuming a prevalence
of 5%, this sample size was sufficient to obtain a 1.1% pre-
cision at a 95% confidence level.
Human subjects. Participants, although selected at random
for the survey, underwent the routine diagnosis and treatment
procedure recommended by the NSSCP. Thus, the survey was
considered as initial evaluation and not as research. Patients
identified with confirmed Tbg trypanosomiasis during the sur-
vey were offered treatment. Serologic suspects were also of-
fered counseling and explained the need for follow-up diag-
nostic evaluations four times during one year.
5 The survey
protocol was reviewed and approved by the Ugandan Minis-
try of Health and by the Arua District Medical Office.
RESULTS
Survey results. Description of the survey sample. Only 14 of
the 24 parishes of Terego County could be surveyed because
the fieldwork was interrupted in June 1996 due to civil unrest.
In these 14 parishes (combined estimated 1996 population
size  63,502), 826 persons were included in the survey
TABLE 1
Age and sex distribution of the survey sample in Terego County in
northern Uganda, 1996
Age (years) Female Male Total
<5 35 52.2% 32 47.8% 67
5–14 67 43.8% 86 56.2% 153
15–29 105 41.3% 149 58.7% 254
30–59 126 43.9% 161 56.1% 287
60 23 35.4% 42 64.6% 65
Total 356 43.1% 470 56.9% 826
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57% (Table 1) and the median age was 26 years (range 0−87).
Parish ranking using LQAS analysis. The number of par-
ishes for which there was an 80% probability that the preva-
lence exceeded 2% increased with the sensitivity of the case
definition (Table 2). When the confirmed Tbg trypanosomia-
sis case definition (least sensitive case definition) was used,
only one parish (Ogunu) was considered to have an 80%
probability of exceeding the 2% threshold. This parish was
ranked in the++++category. When the serologically sus-
pected case definition was considered (definition with inter-
mediate sensitivity), an additional three parishes (Yiddu,
Bura, and Erea) were considered to have an 80% probability
of exceeding the 2% threshold. These three parishes were
ranked in the+++category. When a positive CATT result
(most sensitive case definition) was considered as the out-
come of interest, an additional four parishes (Azapi, Otrevu,
Amgazi, and Onzoro) were considered to have an 80% prob-
ability of exceeding the 2% threshold. These four parishes
were ranked in the + + category. Six remaining parishes that
were considered to have a 95% probability of being under
the 10% threshold for the most sensitive case definition
were ranked in the + category. Overall, ranking allowed a
mapping of the area studied to determine which parishes
should be actively screened by a mobile team before the oth-
ers (Figure 1).
Estimated prevalence in the whole county. Of the 826 indi-
viduals in the sample, 51 (6.5%, 95% confidence interval [CI]
 4.7−8.3) had a positive CATT result, 28 (3.6%, 95% CI 
2.3−5.0) were serologically suspected cases, and 16 (2.2%,
95% CI  1.1−3.2) were confirmed Tbg trypanosomiasis case
patients. Of these, 14 (87.5%) had cerebrospinal fluid abnor-
malities suggesting late stage infection. Based upon the preva-
lence estimate of the survey and the projected 1996 popula-
tion size, the number of confirmed Tbg trypanosomiasis cases
in the 14 surveyed parishes was estimated between 699 and
2,032 cases.
Validation of the survey results. Validation of parish rank-
ing. The prevalence of Tbg trypanosomiasis calculated on the
basis of the 1997−1998 first round of active screening in the 14
parishes decreased with each of the four prevalence catego-
ries that had been defined on the basis of the LQAS survey
(0.9%, 0.3%, 0.2%, and 0.1% for the ++++, +++, ++, and +
groups, respectively; 
2  92.7, degrees of freedom  3, P <
0.0001) ( Table 3).
Validation of the estimated prevalence in the whole coun-
ty. In the 14 parishes where the survey was conducted, 683
(prevalence  1.1%) new cases of Tbg trypanosomiasis were
diagnosed through passive (n  463, 67.8%) and active (n 
220, 32.2%) screening between July 1996 and December 1999.
This prevalence was at the lower 95% confidence limit of the
prevalence estimate provided by the survey.
DISCUSSION
This cross-sectional survey provided a pre-intervention es-
timate of the prevalence of Tbg trypanosomiasis in the 14
TABLE 2
Number of positive CATT results, serologically suspected cases, and
cases of Tbg trypanosomiasis in the 14 parishes surveyed in Terego
County in northern Uganda, 1996*
Parish








Ogunu 7† 5‡ 4§ ++++
Yiddu 7† 4‡ 1 +++
Bura 7† 3‡ 2 +++
Erea 6† 4‡ 1 +++
Azapi 5† 20 + +
Otrevu 4† 22 + +
Angazi 4† 10 + +
Onzoro 3† 11 + +
Aripia 2 2 2 +
Owayi 2 2 1 +
Paranga 2 0 0 +
Anufira 1 1 1 +
Obi 1 1 1 +
Orivu 0 0 0 +
Total 51 28 16 –
* CATT  Card Agglutination Trypanosomiasis Test; Tbg  Trypanosoma brucei gam-
biense.
† Parish for which the number of positive CATT results exceeded the critical number
(80% probability of a prevalence exceeding 2%).
‡ Parish for which the number of serologically suspected cases exceeded the critical num-
ber (80% probability of a prevalence exceeding 2%).
§ Parish for which the number of Tbg trypanosomiasis cases exceeded the critical number
(80% probability of a prevalence exceeding 2%).
FIGURE 1. Ranking of parishes in categories on the basis of lot quality assurance sampling analysis in Terego County in northern Uganda, 1996.
HUTIN AND OTHERS 392parishes that could be visited in Terego County. Ranking of
the parishes through LQAS testing allowed defining priorities
for the planning of active case finding campaigns, and the
overall estimate was valuable to plan the long-term activities
of the diagnosis and treatment center in Omugo.
If this survey had not been conducted, two options would
have been available to estimate the prevalence of Tbg trypa-
nosomiasis in Terego County. First, period prevalence esti-
mates based upon cases self-referred at the center could have
been used. The period prevalence estimates based upon self-
referred patients would have required months of activities at
the center. In addition, it may have underestimated the preva-
lence in parishes located far from the center because residents
with little access to the center may have been less likely to
present themselves for diagnosis and treatment. Alterna-
tively, prevalence estimates could have been based upon the
first round of active screening campaigns in all parishes. This
second method would have required more time and more
financial resources, but would have provided a more reliable
estimate. The LQAS survey did not require a first round of
active screening. It provided a ranking of the parishes accord-
ing to their expected prevalence levels. This ranking allowed
directing efforts for the first round of active screening and was
later validated by the results of the first round of active
screening. Finally, it provided an unbiased overall estimate of
the prevalence in the county that was validated by the total
number of patients ultimately diagnosed through passive and
active screening between July 1996 and December 1999.
Surveys using the classic cluster sample methods are useful
in providing overall estimates of diseases prevalence.
12 How-
ever, these surveys cannot measure prevalence estimates for
each visited cluster and they are not adapted to the hetero-
geneous distribution of Tbg trypanosomiasis in endemic ar-
eas. Cross-sectional surveys using the LQAS method address
some of the limitations of traditional methods. First, LQAS
provides an opportunity to test the hypothesis that the preva-
lence of disease in certain communities exceeds a certain
threshold with a high sensitivity but a low specificity.
13 In this
survey, use of LQAS dichotomous testing for three case defi-
nitions of increasing specificity allowed ranking parishes ac-
cording to the specificity of the case definition. Second,
LQAS with single random sampling in every village is less
sensitive than cluster sampling to the heterogeneous distribu-
tion of Tbg trypanosomiasis in the population. Finally, use of
stratified single random sampling allowed us to generate es-
timates for the parishes that had been visited despite the cur-
tailing of the study at mid-course. For this study, a traditional
stratified survey could also have estimated the prevalence in
each visited strata. However, a traditional stratified survey
would have been limited by the issue of sample size. Had we
analyzed our data as a traditional stratified survey to compare
prevalences across parishes, our limited sample size would
have lead to large confidence intervals that would have not
allowed us to form any conclusions. As an example, the
prevalence of a positive CATT result in Ogunu (7 of 59,
11.8%, 95% CI  4.9−23) would not have been significantly
different from the prevalence of a positive CATT result in
Obi (1 of 59, 1.7%, 95% CI  0.04−9.1).
This survey had several limitations. Despite our attempt to
sample randomly, the representation of the sample was not
what had been aimed for. First, the proportion of males
among participants suggested that they were over-represent-
ed. This over-representation cannot be confirmed since the
proportion of males in the 1996 population was unknown and
could have been affected by population movements associ-
ated with civil unrest in the district. Second, the heteroge-
neous distribution of Tbg trypanosomiasis within villages may
have lead to the selection of biased samples within parishes.
While this factor could have affected the LQAS ranking of
the parishes, it is unlikely that it would have biased the overall
prevalence since underestimates and overestimates would be
expected to cancel each other out at the county level. Third,
sampling of a single individual per household over-represent-
ed small households and under-represented large households.
However, there is no data to suggest that the prevalence of
Tbg trypanosomiasis varies according to the household size.
Finally, the reduction in overall sample size secondary to the
early termination of the survey increased the width of our
confidence interval. However, our estimate was still compat-
ible with the period prevalence obtained with the validation
method.
Cross-sectional surveys using LQAS are based upon single
random sampling in communities. Single random sampling
requires a sampling frame, time, attention, and expertise. In
the specific field of Tbg trypanosomiasis, it is also necessary to
have an infrastructure to diagnose and treat survey partici-
pants before a survey is initiated. In addition, results of LQAS
surveys are sometimes difficult to communicate to public
health audiences that are not familiar with its principles.
14
Finally, an LQAS survey will never replace mass screening
campaigns that remain the gold standard for estimating vil-
lage-specific prevalences of Tbg infection, in part because
prevalence levels below 10% make it difficult to estimate
prevalence with a satisfying degree of precision during sur-
TABLE 3
Comparison between the categories obtained through the LQAS
analysis of the 1996 survey and the prevalence obtained during the




the 1996 LQAS survey
Prevalence based upon the first round of active
screening in Terego County, 1997–1998
Tbg cases Total Prevalence (%)
Ogunu 42 4,605 0.9
Total 42 4,605 0.9†
Yiddu 15 4,359 0.3
Bura 11 4,138 0.3
Erea 11 2,093 0.5
Total 37 10,590 0.3†
Azapi 3 4,519 0.1
Otrevu 8 2,872 0.3
Angazi NA NA NA
Onzoro 12 3,792 0.3
Total 23 11,183 0.2†
Aripia 5 3,112 0.2
Owayi 5 4,309 0.1
Paranga 2 3,474 0.1
Anufira 8 2,683 0.3
Obi 5 3,583 0.1
Orivu 0 4,194 0
Total 25 21,355 0.1†
Total 127 47,733 0.1
* LQAS  lot quality assurance sampling; Tbg = Trypanosoma brucei gambiense; NA 
not available.
† General chi-square for the comparison of Tbg trypanosomiasis prevalence among the
four categories  92.7, degrees of freedom  3, P < 0.0001.
TRYPANOSOMIASIS IN UGANDA 393veys. For all these reasons, surveys using LQAS to assess the
prevalence of Tbg trypanosomiasis cannot be currently rec-
ommended as a standard method for initial evaluation. How-
ever, in some circumstances, expertise may be present, labo-
ratory capacity may be available, public health audiences may
understand advanced LQAS analysis, and mass screening
campaigns may be difficult to organize rapidly. In such set-
tings, cross-sectional surveys using LQAS may be a useful
tool to estimate prevalence and to identify small communities
(e.g., parishes, villages) that should be screened during the
first round of active screening campaigns. Availability of such
data would allow that scarce resources available to sleeping
sickness control programs be used in a more cost-effective
way.
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